2025 annual financial data
Acumen Pharmaceuticals 2025 Operating margin
Acumen Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -123,832,000 USD and net income was -121,335,000 USD.
Operating cash flow was -115,538,000 USD.
Get free Acumen Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -123,832,000 USD
- Net income
- -121,335,000 USD
- Operating cash flow
- -115,538,000 USD